siRNA could be a potential therapy for COVID-19

dc.contributor.authorGhosh, Sanhita
dc.contributor.authorFirdous, Sayeed Mohammad
dc.contributor.authorNath, Anirban
dc.date.accessioned2020-12-17T14:42:55Z
dc.date.available2020-12-17T14:42:55Z
dc.date.issued2020-04-22
dc.identifier.citationGhosh, S., Firdous, S. M., & Nath, A. (2020). siRNA could be a potential therapy for COVID-19. EXCLI Journal, 19, 528-531. https://doi.org/10.17179/excli2020-1328de
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/39928
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21818
dc.language.isoen
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, pp. 528-531
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19en
dc.subject.ddc610
dc.titlesiRNA could be a potential therapy for COVID-19en
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/2287
eldorado.secondarypublicationtrue

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Firdous_22042020_proof.pdf
Size:
28.32 KB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description: